Mereo Biopharma Group Plc ADR (NASDAQ:MREO) currently has a daily average trading volume of 1.16M but it saw 706218 shares traded in last market. With a market cap of 704.22M USD, the company’s current market price of $4.58 came falling about -1.93 while comparing to the previous closing price of $4.67. In past 52 weeks, the stock remained buoying in the range of price level as high as $5.02 and as low as $1.07. In the recent trading on the day, stock has struck highest price mark of $4.5691 while lowest mark touched by it was $4.84.
Taking a look at 20-day trading activity of Mereo Biopharma Group Plc ADR (MREO) gives its current price level -8.76% below from 52-week high level whereas it is 328.04% above from lowest level seen by the stock during that period. A closer look into the stock’s movement over the week reveals that its volatility is standing at 5.40% during that period while stretching the period over a month that increases to 6.34%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 61.42 which implies that the stock is in neutral territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Robert W. Baird which initiated the stock as “Outperform” in its note to investors issued on June 13, 2024, recommending a price target of $8 for it. Cantor Fitzgerald also issued its recommendations for the stock as it initiated the price target for the stock is $4.
Over the week, MREO’s stock price is moving 1.55% up while it is 12.81% when we observe its performance for the past one month. Year-to-date it is 98.27% up and over the past year, the stock is showing an upside performance of 213.70%.
Currently, Mereo Biopharma Group Plc ADR’s total number of outstanding shares is 153.76M. Company’s return on investment (ROI) stands at -39.47% and return on equity (ROE) at -39.59%. Stock’s beta reads 0.96. Stock has a price to book (P/B) ratio of 8.95 while price to sale or P/S ratio amounts to 80.12. Its return on asset (ROA) is -26.75% on average.
